Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
Clinical trial NCT00624182 · SUSPENDED
Trial details
- NCT number
- NCT00624182
- Sponsor
- Akita University Hospital
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.